Contact this trialFirst, we need to learn more about you.
Ruxolitinib + Stem Cell Transplant for Acute Myeloid Leukemia
Recruiting3 awardsPhase 2
Columbus, Ohio
This trial is studying ruxolitinib to see how well it works in preventing relapse in people with acute myeloid leukemia who have undergone allogeneic stem cell transplantation.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service